Asymptomatic and symptomatic SARS-CoV-2 infections after BNT162b2 vaccination in a routinely screened workforce
L Tang, DR Hijano, AH Gaur, TL Geiger, EJ Neufeld… - Jama, 2021 - jamanetwork.com
Methods| In March 2020, St Jude Children's Research Hospital initiated routine, test-based
screening of asymptomatic workers and targeted testing for symptomatic individuals and …
screening of asymptomatic workers and targeted testing for symptomatic individuals and …
[引用][C] Asymptomatic and Symptomatic SARS-CoV-2 Infections After BNT162b2 Vaccination in a Routinely Screened Workforce
L Tang, DR Hijano, AH Gaur, TL Geiger, EJ Neufeld… - JAMA, 2021 - cir.nii.ac.jp
Asymptomatic and Symptomatic SARS-CoV-2 Infections After BNT162b2 Vaccination in a
Routinely Screened Workforce | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
Routinely Screened Workforce | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
Asymptomatic and Symptomatic SARS-CoV-2 Infections After BNT162b2 Vaccination in a Routinely Screened Workforce.
L Tang, DR Hijano, AH Gaur, TL Geiger, EJ Neufeld… - JAMA, 2021 - europepmc.org
Methods In March 2020, St Jude Children's Research Hospital initiated routine, test-based
screening of asymptomatic workers and targeted testing for symptomatic individuals and …
screening of asymptomatic workers and targeted testing for symptomatic individuals and …
[引用][C] Asymptomatic and Symptomatic SARS-CoV-2 Infections After BNT162b2 Vaccination in a Routinely Screened Workforce
L Tang, DR Hijano, AH Gaur, TL Geiger… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Asymptomatic and Symptomatic SARS-CoV-2 Infections After BNT162b2 Vaccination in a
Routinely Screened Workforce Asymptomatic and Symptomatic SARS-CoV-2 Infections After …
Routinely Screened Workforce Asymptomatic and Symptomatic SARS-CoV-2 Infections After …
[HTML][HTML] Asymptomatic and Symptomatic SARS-CoV-2 Infections After BNT162b2 Vaccination in a Routinely Screened Workforce
L Tang, DR Hijano, AH Gaur, TL Geiger, EJ Neufeld… - JAMA, 2021 - covid19.sld.cu
Asymptomatic and Symptomatic SARS-CoV-2 Infections After BNT162b2 Vaccination in a
Routinely Screened Workforce | Occupational Health | JAMA | JAMA Network [Skip to …
Routinely Screened Workforce | Occupational Health | JAMA | JAMA Network [Skip to …
[HTML][HTML] Asymptomatic and Symptomatic SARS-CoV-2 Infections After BNT162b2 Vaccination in a Routinely Screened Workforce
L Tang, DR Hijano, AH Gaur, TL Geiger, EJ Neufeld… - JAMA, 2021 - ncbi.nlm.nih.gov
Methods In March 2020, St Jude Children's Research Hospital initiated routine, test-based
screening of asymptomatic workers and targeted testing for symptomatic individuals and …
screening of asymptomatic workers and targeted testing for symptomatic individuals and …
Asymptomatic and symptomatic SARS-CoV-2 infections after BNT162b2 vaccination in a routinely screened workforce.
L Tang, DR Hijano, AH Gaur, TL Geiger, EJ Neufeld… - 2021 - cabidigitallibrary.org
A 2-dose regimen of the BNT162b2 vaccine (Pfizer-BioNTech) against SARS-CoV-2 was
authorized in December 2020 based on reported 94.8% efficacy. Although an association …
authorized in December 2020 based on reported 94.8% efficacy. Although an association …
Asymptomatic and Symptomatic SARS-CoV-2 Infections After BNT162b2 Vaccination in a Routinely Screened Workforce
L Tang, DR Hijano, AH Gaur, TL Geiger, EJ Neufeld… - covid19.sld.cu
A 2-dose regimen of the BNT162b2 vaccine (Pfizer-BioNTech) against SARS-CoV-2 was
authorized in December 2020 based on reported 94.8% efficacy. Although an association …
authorized in December 2020 based on reported 94.8% efficacy. Although an association …
Asymptomatic and Symptomatic SARS-CoV-2 Infections After BNT162b2 Vaccination in a Routinely Screened Workforce.
L Tang, DR Hijano, AH Gaur, TL Geiger, EJ Neufeld… - JAMA, 2021 - europepmc.org
Methods In March 2020, St Jude Children's Research Hospital initiated routine, test-based
screening of asymptomatic workers and targeted testing for symptomatic individuals and …
screening of asymptomatic workers and targeted testing for symptomatic individuals and …